LIGUORI, VALERIO
 Distribuzione geografica
Continente #
EU - Europa 47
AS - Asia 13
NA - Nord America 13
Totale 73
Nazione #
IT - Italia 37
US - Stati Uniti d'America 13
SG - Singapore 9
IE - Irlanda 7
CN - Cina 3
FI - Finlandia 1
IN - India 1
NL - Olanda 1
RS - Serbia 1
Totale 73
Città #
Naples 11
Aversa 9
Dublin 7
Singapore 5
Milan 4
Rome 4
Salerno 3
New York 2
Amsterdam 1
Boardman 1
Casavatore 1
Castellammare di Stabia 1
Catania 1
Hyderabad 1
Kragujevac 1
Lappeenranta 1
Rho 1
Sorrento 1
Vico Equense 1
Totale 56
Nome #
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System 22
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data 12
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study 12
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis 10
A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database 9
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database 8
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria 7
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 4
Totale 84
Categoria #
all - tutte 671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20237 0 0 0 0 0 0 0 0 0 4 1 2
2023/202473 3 1 10 5 14 2 0 7 11 1 9 10
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 84